The Washington Court of Appeals this month revived a legal fight against health insurers’ blanket refusals to cover weight loss medications like Ozempic and Wegovy.In a decision published May 4, the court ruled that insurance plans that prohibit certain types of obesity treatment could potentially violate state antidiscrimination law.Over the past few years, weight loss medications known as GLP-1 drugs have exploded in popularity. The drugs are …